This site complies with the HONcode standard for trustworthy health information: verify here.

Deputy Director of the CEBM, GP and clinical lecturer at the University of Oxford.

Cardiology trainee and clinical research fellow at the University of Oxford

See Carl Heneghan in action in the CEBM's workshop videos.
Click here
Coronary heart disease (CHD), which usually presents as a heart attack (or myocardial infarction, MI) is the most common cause of death and disability both in the UK and globally. The way in which CHD is treated and prevented therefore has huge implications for patients, health professionals and policymakers. Once a person has a heart attack, prevention of further heart attacks, stroke or death, or secondary prevention, is crucial. There is strong evidence for benefit of several drugs and treatments after heart attacks to this end, including aspirin, statins, ACE inhibitors and beta-blockers.
Recent comments
3 weeks 1 day ago
6 weeks 2 days ago
6 weeks 2 days ago
6 weeks 2 days ago
6 weeks 5 days ago
6 weeks 6 days ago
7 weeks 3 days ago
7 weeks 3 days ago
9 weeks 37 min ago
9 weeks 2 hours ago